Anflu (trivalent influenza virus split vaccine)
/ Sinovac
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
September 22, 2026
A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Women (AnFLU-PREG)
(clinicaltrials.gov)
- P4 | N=150 | Not yet recruiting | Sponsor: Sinovac Biotech Co., Ltd
New P4 trial • Infectious Disease • Influenza • Respiratory Diseases
1 to 1
Of
1
Go to page
1